Dr. Michael Joseph Cavnar, MD

Dr. Cavnar practices at University of Kentucky Albert B. Chandler Hospital in Lexington, Kentucky, part of University of Kentucky HealthCare.

Dr. Cavnar's NPI, 1699970426, was assigned on June 20, 2007. Dr. Cavnar graduated from Columbia University Vagelos College of Physicians and Surgeons in 2007. Dr. Cavnar holds Kentucky license 50189.

Dr. Cavnar's primary practice is University of Kentucky Albert B. Chandler Hospital, at 800 Rose Street, Lexington, KY 40536 in Fayette County. The practice phone is (859) 257-2278.

Dr. Cavnar's primary practice is University of Kentucky Albert B. Chandler Hospital in Lexington, Kentucky, part of University of Kentucky HealthCare. The medical group on file is University of Kentucky General Pediatrics.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cavnar practices. Vendor and product names are available with a free account.

Surgical oncology is Dr. Cavnar's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dmand AI has Dr. Cavnar's licenses on file in 2 states: Kentucky and New York.

Dmand AI lists abdominal adhesion surgery and colon removal among the conditions Dr. Cavnar treats.

CMS data shows 248 Medicare services from Dr. Cavnar across 7 procedure codes in 2024, for 135 Medicare patients. Medicare paid $24,119 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 135 Medicare patients who saw Dr. Cavnar in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cavnar's median patient age at 70, with 55% women.

In 2024, Dr. Cavnar wrote 295 Medicare Part D claims for 82 patients. 56% of them were for generic drugs. CMS names the drug for 172 of them, across 5 drugs with 11 or more claims each, at $391,089 in total drug cost. In 2023, CMS named 214 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Cavnar for performance year 2024, reported as part of a group. Dr. Cavnar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cavnar as offering telehealth.

Dmand AI links 55 papers to Dr. Cavnar, published from 2010 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Gastrointestinal Stromal Tumors, Imatinib Mesylate and Colorectal Neoplasms. Dr. Cavnar has published most often in Ann Surg Oncol. Dr. Cavnar's most frequent co-authors are Ronald P. Dematteo, MD, Vinod P. Balachandran, MD and Prakash Krishman Pandalai, MD.

Dmand AI links Dr. Cavnar to 2 clinical trials, 2 of them phase 2 studies.

CMS Open Payments shows 29 general payments to Dr. Cavnar from 12 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 55% of the total. Intuitive Surgical, Inc. paid the most, $1,226.

Dmand AI lists 4 awards for Dr. Cavnar, most recently Clinical Teaching Award in 2018.

Dr. Cavnar graduated from Columbia University Vagelos College of Physicians and Surgeons in 2007.

Dr. Cavnar is in network with 18 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.